Login / Signup

CompLement C5 Antibodies for decreasing brain injury after aneurysmal Subarachnoid Haemorrhage (CLASH): study protocol for a randomised controlled phase II clinical trial.

Inez KoopmanGabriel J E RinkelMervyn D I Vergouwennull null
Published in: Trials (2020)
Netherlands Trial Register NTR6752 . Registered on 27 October 2017 European Clinical Trials Database (EudraCT) 2017-004307-51.
Keyphrases
  • phase ii
  • brain injury
  • clinical trial
  • study protocol
  • subarachnoid hemorrhage
  • open label
  • phase iii
  • double blind
  • cerebral ischemia
  • adverse drug
  • emergency department
  • drug induced